HAIXI PHARMA(02637): Lam Wai Yee appointed as Joint Company Secretary.
Haisi Pharmaceuticals (02637) announced that Ms. Chen Xiaolin has resigned as (i) Joint Company Secretary of the company; (ii) ...
HAIXI PHARMA (02637) announces that Ms. Chen Xiaolin has resigned as (i) Joint Company Secretary of the Company; (ii) Company authorized representative as defined under Rule 3.05 of the Listing Rules of the Stock Exchange of Hong Kong Limited; (iii) Company authorized representative under Part 16 of the Companies Ordinance (Chapter 622 of the Laws of Hong Kong); and (iv) Company authorized person to accept legal process documents and notices in Hong Kong as specified under Rule 19A.13(2) of the Listing Rules, with effect from November 21, 2025.
Ms. Lam Wai Yi has been appointed as the Joint Company Secretary, authorized representative, and legal process agent of the Company, with effect from November 21, 2025.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
